戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 39作成日:2026年10月23日

N-(4-chloropyridin-2-yl)cyclopropanecarboxamide → N-[4-[(6-Chloro-[1,3]dioxolo[4,5-B]pyridin-7-Yl)amino]-2-Pyridyl]cyclopropanecarboxamide

https://huagongshe.com/ja/reaction/39

反応式

関与物質

役割名称HCID仕込み量
反応物N-(4-chloropyridin-2-yl)cyclopropanecarboxamideHCID 4394171—
反応物6-chloro-2H-[1,3]dioxolo[4,5-b]pyridin-7-amineHCID 68548651—
試薬1,8-Diazabicyclo(5.4.0)undec-7-eneHCID 81184—
触媒1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
触媒(1E,4E)-1,5-diphenylpenta-1,4-dien-3-one; palladiumHCID 6505921—
溶媒TolueneHCID 1140—
生成物N-[4-[(6-Chloro-[1,3]dioxolo[4,5-B]pyridin-7-Yl)amino]-2-Pyridyl]cyclopropanecarboxamideHCID 12123240132.5%

反応条件

温度130 °C

反応手順

2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine (0.190 mL, 1.27 mmol) was added to a mixture of N-(4-chloropyridin-2-yl)cyclopropanecarboxamide (100 mg, 0.51 mmol), 6-chloro-[1,3]dioxolo[4,5-b]pyridin-7-amine (105 mg, 0.61 mmol) and BIS(DIBENZYLIDENEACETONE)PALLADIUM(0) (26.3 mg, 0.05 mmol) and (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (29.4 mg, 0.05 mmol) in toluene (1 mL) in a microwave tube. The reaction was degased, purged with argon and heated to 130 °C over a period of 7 hours in an oil bath. The mixture was diluted with dichloromethane, washed with water (emulsion), with brine, dried over MgSO4 and concentrated. The crude product was purified by flash chromatography on silica gel eluting with 0 to 3% methanol in dichloromethane. The solvent was evaporated to dryness to afford N-(4-(6-chloro-[1,3]dioxolo[4,5-b]pyridin-7-ylamino)pyridin-2-yl)cyclopropanecarboxamide (55.0 mg, 32.5 %) as a yellow solid.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-1aa2de1a9b014f58b717c720b31e4a66
出典メモ750 AstraZeneca ELN dataset